Persistent infection with high-risk human papillomaviruses (HPVs), especially type 16 has been undeniably linked to cervical cancer. The Asian-American (AA) variant of HPV16 is more common in the Americas than the prototype in cervical cancer. The different prevalence is based on three amino acid changes within the E6 protein denoted Q14H/H78Y/L83V. To investigate the mechanism(s) behind this observation, both E6 proteins, in the presence of E7, were evaluated for their ability to extend the life span of and transform primary human foreskin keratinocytes (PHFKs). Longterm cell culture studies resulted in death at passage 9 of vector-transduced PHFKs (negative control), but survival of both E6 PHFKs to passage 65 (and beyond). Compared with E6/E7 PHFKs, AA/E7 PHFKs were significantly faster dividing, developed larger cells in monolayer cultures, showed double the epithelial thickness and expressed cytokeratin 10 when grown as organotypic raft cultures. Telomerase activation and p53 inactivation, two hallmarks of immortalization, were not significantly different between the two populations. Both were resistant to anoikis at later passages, but only AA/E7 PHFKs acquired the capacity for in vitro transformation. Proteomic analysis revealed markedly different protein patterns between E6/E7 and AA/E7, particularly with respect to key cellular metabolic enzymes. Our results provide new insights into the reasons underlying the greater prevalence of the AA variant in cervical cancer as evidenced by characteristics associated with higher oncogenic potential.
Introduction
The human papillomaviruses (HPVs) comprise over 100 numerically designated genotypes, of which types 16 and 18 cause the vast majority of cervical cancer worldwide (Castellsague, 2008) . Further diversity arises within any given HPV genotype through limited nucleotide changes in the coding (at a frequency of o2%) and non-coding (at a frequency of o5%) regions (Bernard et al., 2006) . Such variants phylogenetically segregate based on their geographical origin and are therefore labeled European, African, Asian, Asian-American (AA) and North American. Significant differences in pathogenicity exist between variants within a single genotype. These differences have been elucidated most clearly for HPV16. Multiple studies have shown that HPV16 variants differ in their association with cervical cancer (Tidy et al., 1989; Berumen et al., 2001; Zehbe et al., 1998a Zehbe et al., , b, 2001 Kammer et al., 2002; Xi et al., 2007) , viral persistence (Grodzki et al., 2006; Xi et al., 2006; Lee et al., 2008) and the frequency of recurrence of cervical disease (Xi et al., 2007) . Increased risk of anal cancers has also been reported for certain HPV16 variants (Xi et al., 1998) . Genomic variation and a 2 00 000 year evolutionary timeline have been presented as reasons why HPV16 is the most prevalent HPV genotype in cervical and other human cancers (Bernard, 2005) .
A majority of the functional and mechanistic studies on HPV16 have been carried out using the prototype of the transforming early-expressed protein, E6 (reviewed in Seedorf et al., 1985; Zehbe et al., 1998a) , while only five studies have looked at HPV16 E6 variants (Sto¨ppler et al., 1996; Chakrabarti et al., 2004; Lichtig et al., 2006; Asadurian et al., 2007; Zehbe et al., 2009) . The HPV16 E6 prototype and variants differ in their: binding to the calcium-binding protein, E6-PB (Lichtig et al., 2006) , an E6 target involved in differentiation, activities in abrogating serum/calcium-induced differentiation (Asadurian et al., 2007) , expression of cytokeratins in organotypic cultures (Zehbe et al., 2009 ) and transformation of a spontaneously immortalized aneuploid human keratinocyte cell line, (HaCaT; described by Boukamp et al., 1988) (Chakrabarti et al., 2004) .
A non-European, naturally occurring E6 variant of HPV16-the AA variant-is found up to 20 times more often in cervical cancer in the Americas than the prototype (Xi et al., 1997; Berumen et al., 2001 Berumen et al., , 2007 . Compared with HPV16 prototype, AA differs by three amino acid changes within its E6 protein denoted Q14H/H78Y/L83V. Interestingly, amino acid changes at positions 14 and 83 were found to be under Darwinian selective pressure (Chen et al., 2005) . On the basis of the predicted structural HPV16 E6 model, these residues are buried, there by effecting the stability and function of the E6 protein (Nomine et al., 2006) . Two nonexclusive mechanisms may explain the greater association of the AA variant with cervical cancer: more efficient evasion of host immune surveillance and increased oncogenic potential (Zehbe et al., 2003; de Araujo Souza et al., 2009) .
In this study, we wished to test the hypothesis that the AA variant has increased oncogenic potential, and in doing so, shed light on the mechanisms behind AA's increased pathogenicity. Specifically, we compared the abilities of the prototype and AA E6 proteins to extend the life span (immortalize) and transform long-term cultures of primary human foreskin keratinocytes (PHFKs) in the presence of the E7 oncoprotein that is normally co-expressed with E6 in cervical cancers.
Results
AA/E7-and E6/E7-transduced PHFKs differ in their proliferation potential and epithelial differentiation profile PHFKs have a limited lifespan, undergo senescence (crisis) and eventually die. The E6 protein of high-risk HPV, in the presence of E7, is known to overcome initial crisis and lead cells into immortalization (Kaur and McDougall, 1989) . What was unknown was whether the HPV16 AA variant, in conjunction with the HPV16 E7 protein, is a more powerful immortalizing agent than is the HPV16 prototype E6/E7. The endpoint of our immortalization study was 65 passages, which is well accepted to represent an infinite life span (Boukamp et al., 1988; Woodworth et al., 1988; Shen et al., 2004) . The expression of prototype and variant HPV16 E6 genes as well as the HPV16 E7 prototype gene was higher at endpoint passage 65 than at early, that is, passage 6, which is in concordance to what has been reported previously for E6 (Fu et al., 2003) (Figure 1) .
As a result of repressing the tumor suppressor protein retinoblastoma by E7, the cyclin-dependent kinase inhibitor p16 is overexpressed in cervical cancer. As expected, we found western blot levels of p16 to be similarly high in the two populations between passages 16 and 65 while the negative control, vector-transduced PHFKs contained barely detectable amounts of p16 (Figure 2 ). This illustrates that E7 has similar effects in both prototype E6/E7-and AA/E7-transduced keratinocytes and that differences noted between the two populations are caused by the differences between the E6 proteins.
AA/E7-transduced PHFKs were first to reach the endpoint of passage 65, after 403 days in culture. E6/ E7-transduced PHFKs, on the other hand, needed 522 days to reach passage 65 (Figure 3a) (Figure 3b ). This shortened crisis period doubling time contributed, in part, to the AA/E7 populations reaching the endpoint sooner. and AA/E7 PHFKs, respectively), which also contributed to AA/E7 populations reaching the endpoint sooner than E6/E7 populations. Variant AA/E7 PHFKs had larger cell morphology than did prototype E6/E7-tranduced PHFKs when grown on plastic (Figure 4a ). In three-dimensional HPV16 E6 variants C Richard et al organotypic raft cultures, the AA/E7 populations reached an epithelial thickness at least twice that of prototype E6/E7 cultures (Figure 4a ), consistent with the variant AA/E7 populations being more hyperplastic than the prototype E6/E7 populations. Both AA/E7 and E6/E7 populations showed epithelial changes in raft cultures comparable to a high-grade squamous intraepithelial lesion. Only AA/E7 showed suprabasal epithelial layers consisting of highly keratinized and atypical cells. Ki67, a marker to determine the growth fraction of a given cell population (Schonk et al., 1989) was observed in single cells within the lower, and interestingly, also the upper (keratinizing) part of the AA/E7 raft epithelium, as well as in single cells of the E6/E7 raft epithelium (Figure 4b ). Although differentiation-associated cytokeratin 10 (K10), was found in the majority of suprabasal cells within the AA/E7 culture, the E6/E7 culture was devoid of any K10 staining ( Figure 4b ). Proliferation-associated K5, which normally is present in basal cell layers of normal stratified squamous epithelium (Zehbe et al., 2009 ) was expressed within all cells of the E6/E7 raft epithelium. In the AA/E7 raft, K5 was detected within all cells of the lower half of and within a subset of cells of the upper half of the epithelium, with consequent overlapping of K5 and K10 expression ( Figure 4b ). It is noteworthy that a subset of Ki67-positive cells was found in an area of K10-positive cells within the upper part of the AA/E7 raft (white arrow in Figure 4b ).
Telomerase activation and p53 inactivation are similar in the E6/E7 and AA/E7 cultures Telomerase activation and p53 inactivation, and with that the onset of genomic instability are two important events in carcinogenesis (Hanahan and Weinberg, 2000) . The E6 protein of high-risk HPV induces cellular telomerase activity (Klingelhutz et al., 1996) and degrades p53 (Huibregtse et al., 1991) , the latter through ubiquitin-dependent (Scheffner et al., 1993) and ubiquitin-independent mechanisms (Camus et al., 2007) . Telomerase activation (Klingelhutz et al., 1996) and p53 inactivation (Dalal et al., 1996; McMurray and McCance, 2004) have both been implicated as mechanisms by which the E6 protein induces immortalization of human epithelial cells.
We carried out biochemical studies to determine if the differences between the E6 prototype and variant protein lie at the level of telomerase induction. Telomerase activity correlates with levels of hTERT messenger RNA (Kyo et al., 1999; Sumida et al., 1999; Shamanin et al., 2008) , which is the rate-limiting determinant of the enzymatic activity of telomerase (Kyo et al., 1999) . Consequently, we measured hTERT messenger RNA levels using quantitative reverse transcriptase-PCR (Kirkpatrick et al., 2004 based on sensitive and specific Taqman chemistry previously optimized in our laboratory (DeCarlo et al., 2008) . We found hTERT expression to be lowest (and at the same levels) at passage 6 for the negative control, E6/E7, and AA/E7 cultures. E6 alone induces telomerase expression and activity modestly, with further increases observed once cells have undergone crisis (Sprague et al., 2002; James et al., 2006) . The levels of hTERT in the E6/E7-and AA/E7-transduced cultures increased steadily, peaking at passage 65 ( Figure 5 ). Statistically significant differences were noted at passages 16, 30 and 65 compared with parental PHFKs, but not between the E6/E7 and AA/E7 populations.
We functionally characterized the degree to which prototype or variant HPV16 E6 proteins inactivate p53, another target of E6 implicated in immortalization. Western blots were performed at passages 16, 30 and 65. Levels of total p53 protein in this study were similarly undetectable in both the E6/E7 and AA/E7 PHFK cultures at all passages tested, while early passage parental PHFKs showed strong expression levels ( Figure 2 ). We also compared the capacity of the HPV16 prototype and AA E6 proteins to overcome DNA damage-induced inhibition of DNA synthesis and cell cycle arrest, two activities correlating with E6's ability to inactivate p53 (Song et al., 1998) . Cells were treated with actinomycin D (AD) followed by cell cycle analysis. Both E6/E7 and AA/E7 cultures overcame G1 arrest after AD treatment at passages 16, 30 and 65 and showed a significantly higher resistance than the parental control keratinocytes, which showed G1 arrest when treated with AD ( Figure 6a ). The G1/S ratio of the AD and untreated samples of the prototype and AA E6-transduced keratinocytes ranged between 0.64 and 1.1 (mean values of the passages tested; not significantly different) while the G1/S ratio of vector-transduced keratinocytes was approximately 2.5 and significantly different from E6/E7 and AA/E7 PHFKs (Figure 6b ).
Resistance to detachment-induced cell death (anoikis) is similar in E6/E7 and AA/E7 cells but only AA/E7 cells show signs of transformation in vitro In vivo, when detached from the basal membrane, primary keratinocytes are committed to anoikis, E 6 / E 7 P 1 6 E 6 / E 7 P 3 0 E 6 / E 7 P 6 5 A A / E 7 P 6 A A / E 7 P 1 6 A A / E 7 P 3 0 A A / E 7 P 6 5 H e l a P H F K Figure 5 hTERT transcription levels. HPV16 E6 variants C Richard et al terminal differentiation followed by programmed cell death. Anoikis is triggered by the extrinsic death receptor pathway (Marconi et al., 2004) , and it can be reproduced in the laboratory by plating cells in semisolid medium. During oncogenesis, transformed cells are much less prone to undergo apoptosis and can survive detachment from the basal membrane (or substrate). Compared with keratinocytes transduced with vector alone, E6/E7 and AA/E7 cultures were significantly more resistant to apoptosis when grown in semi-solid medium (Figure 7 ). This resistance was enhanced to the same extent in both cultures at passage 30. Although the E6/E7 culture seemed more resistant than the AA/E7 culture at passage 65, these differences were not statistically significant. Thus, detachment/anchorageindependent survival was comparable between E6/E7 and AA/E7 PHFKs.
Anchorage-independent growth is considered the most accurate and stringent in vitro assay to detect fully transformed cells (Androphy et al., 1985) . This has been reported to occur at low efficiency in human fetal esophageal epithelial cells in the presence of HPV18 E6/E7 at passage 65 (Shen et al., 2004) . In this study, passage 65 E6/E7 and AA/E7 cultures were assessed for their ability to form colonies when grown in semi-soft agar. Rather than resorting to the traditional, subjective method of manually counting and estimating the size of colonies (Hahn et al., 1999) , we used an assay that allowed additional quantification (described in detail in the Materials and methods section). The AA/E7 PHFKs and HeLa cells (positive control) showed colony growth after 10 days. In contrast, the E6/E7 prototype culture and the negative control cells (parental PHFKs) were unable to produce colony growth (Figure 8 ). This observation was confirmed by quantifying cell transformation as determined by cell viability using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (Figure 8 ).
Host cellular proteins associated with metabolic enzymes are differentially expressed in E6/E7-and AA/E7-transduced keratinocytes To identify possible E6 targets for the differences observed in the immortalization and transforming ability, we performed proteomics analyses using two-dimensional gel electrophoresis and matrix-assisted laser desorption/ ionization mass spectroscopy on the passage 65 E6/E7 and AA/E7 PHFKs, as well as on parental PHFKs.
We compared data acquired from three independent two-dimensional gel electrophoresis experiments. The average spot number per gel set ranged from 371 to 383 and a total of 564 spots from all the gels were present in the final master composite (Table 1) . Using the software PD Quest (Bio-Rad Laboratories, Hercules, CA, USA), a total of 28 protein spots that were expressed at significantly different levels in at least two of the pairwise comparisons between the cell types were identified. Six of the protein spots were indistinct and not identifiable. Of the 22 cut spots, 14 spots revealed proteins that were similarly expressed between E6/E7 and AA/E7 gels, but differed in intensity from parental 
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PHFKs. Five of these had not been reported earlier (14-3-3 protein zeta/delta, Ras-related protein Rab-30, protein DJ-1, transketolase and far upstream elementbinding protein 1 (DNA helicase V)) and eight proteins revealed expression levels that were significantly different between the E6/E7 and AA/E7 gels (Table 2 ). These differentially expressed proteins are known to have metabolic functions in the cell (Table 2, Figure 9 ). Enzymes of amino acid metabolism and the tri-carboxylic acid cycle-cytoplasmic isocitrate dehydrogenase 1 (IDH1) as well as mitochondrial IDH2 and malate dehydrogenase-1-were all expressed to a lesser extent in the AA/E7 than the E6/E7 PHFKs. In contrast, glycolytic pathway enzymes-glyceraldehyde 3-phosphate dehydrogenase and pyruvate kinase M2-were found to be significantly increased in AA/E7 compared with E6/E7 PHFKs (Table 2, Figure 9 ). In addition, the protein SET (a nuclear oncogene), which is known to bind to glyceraldehyde 3-phosphate dehydrogenase (Carujo et al., 2006) , was also expressed significantly higher in AA/E7 compared with E6/E7 PHFKs (Table 2, Figure 9 ). Finally, we observed a significant reduction in phosphoglucomutase-2 (regulatory enzyme in cellular glucose utilization) and the aldo-ketoreductase protein (AKR1C1) (a 20-a hydroxysteroid dehydrogenase involved in the reduction and elimination of progesterone) in AA/E7 compared with E6/E7 PHFKs (Table 2, Figure 9 ).
Discussion
We analyzed two common HPV16 strains, as defined by their E6 protein in cultured PHFKs. Our longitudinal cell culture studies investigating the immortalizing and transforming abilities of naturally occurring E6 variants in primary host cells of HPV are the first of their kind. Our results provide a mechanistic explanation for epidemiological studies reporting that the HPV16 E6 AA variant is up to 20-fold more prevalent than the E6 prototype in cervical cancer (Berumen et al., 2001) . AA/E7 showed faster growth and a dissimilar differentiation phenotype compared with E6/E7. There is no significant difference between the E6/E7 and AA/E7 at passage 16, 30 or 65. The Student's t-test was used for statistical analysis. Abbreviations: AA, Asian-American; CV, coefficient of variation; PHFK, primary human foreskin keratinocyte; 2D, two-dimensional. Matched spots after editing are listed for each of three replicate gels containing protein from the parental keratinocytes and the keratinocyte cell lines immortalized with E6/E7 or AA/E7. The mean spot number is shown for each replicate set of three gels, along with the s.d. and the percent coefficient of variation (CV) for each set. Variation between the number of spots per gel is expressed as percent CV (% CV ¼ 100 Â (s.d./mean number of spots detected in gel set)). Student's t-test was performed on the normalized spot density values to find spots that were present in significantly different amounts at the 95% level of confidence in pair-wise comparisons between the AAE7/ E6E7, the AAE7/PHFK and the E6E7/PHFK gel sets. Abbreviations: AA, Asian-American; PHFK, primary human foreskin keratinocyte; ppm, parts per million; 2D, two-dimensional. The eight proteins that were differentially expressed in E6/E7 and AA/E7 PHFKs are indicated in brackets in the first column to the left and are also marked in each of the three gels in Figure 9 . The protein identities for each spot are listed. The other four columns to the left depict the proteins by means of gene identification (Gene ID), accession number (AC), protein identification (Prot ID) and description. Columns to the right depict average spot density values/s.d. across three replicate gels in ppm. Density values were normalized to the total density in each gel. Student's t-test (two-tail, 95% level of confidence) was calculated for pair-wise comparisons to identify proteins that were expressed at significantly different levels in parental PHFKs, PHFKs expressing E6/E7 or AA/E7 proteins. T-statistics indicating significantly different amounts of protein between the gel sets with a 95% confidence level are listed in the final three columns.
PHFK AA/E7 E6/E7 Figure 9 Differential protein expression using two-dimensional (2D) gel electrophoresis. Three independent 2D experiments were performed using parental, E6/E7 and AA/E7 PHFKs. One of the representative gels for each cell type is shown. Rows represent enlarged areas from one of the representative gels containing protein spots, named to the left of each row. Locations of protein spots in the 2D gels that are differentially expressed are shown ringed and numbered: Spot 1 corresponds to the SET protein, spot 2 corresponds to the phosphoglucomutase-2 (PGM2) protein, spot number 3 corresponds to malate dehydrogenase (MDH)1 protein, spot number 4 corresponds to the IDH1 protein, spot 5 corresponds to the AKR1C1 protein, spot number 6 corresponds to IDH2 protein, spot 7 corresponds to the pyruvate kinase M2 (PKM2) protein and spot 8 corresponds to the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) protein. The different spot numbers are also marked in Table 2 in the first column to the left. Rows represent enlarged areas of gels containing protein spots, named to the left of each row. Cell type is listed above each column. Corresponding protein spots are marked with yellow squares in each row. A full colour version of this figure is available at the Oncogene journal online.
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The thickness of the AA/E7 raft was approximately twice that of E6/E7. Only the AA/E7 culture showed a considerable portion of keratinized, atypical cells that were highly differentiated as defined by H þ E and cytokeratin 10 staining, some of which co-expressed the early differentiation marker cytokeratin 5. In addition, a subset of the K10-positive keratinizing cells of the suprabasal compartment stained positive for Ki67 (Figure 4b ), suggesting that AA/E7 is capable of inducing differentiation and proliferation in the same cell. The lack of detectable K10 in the presence of E6 prototype compared with certain E6 variants is not unprecedented and has previously been described by our group (Zehbe et al., 2009 ) using spontaneously immortalized keratinocytes, NIKS (Allen-Hoffmann et al., 2000) .
Interestingly, K10 is not only a differentiation marker for suprabasal keratinocytes but also for reserve cell hyperplasia, immature squamous metaplasia and the cervical transformation zone (Maddox et al., 1999) wherein most cervical carcinomas arise. It has also been reported that cervical intraepithelial neoplasia can be divided into two subpopulations, one characterized by the reserve cell keratin phenotype (K10 positive) and the other by a keratin phenotype typical of non-keratinizing squamous epithelia (Smedts et al., 1993) . In the same study, it was suggested that lesions with the former phenotype are progressive in nature, an observation that further supports the hypothesis that the AA variant is more tumorigenic than is the E6 prototype. Generally, keratinizing squamous cell carcinomas of the cervix often express more K10 than do non-keratinizing squamous cell tumors (Smedts et al., 1992) . It remains to be analyzed whether keratinizing squamous cell carcinomas of HPV16-positive cancers express, to a higher extent, the AA variant than the E6 prototype.
Activities implicated in immortalization and transformation, such as p53 degradation were similar between E6/E7 and AA/E7 PHFKs, paralleling the observation in NIKS (Asadurian et al., 2007; Zehbe et al., 2009) . hTERT induction (a measure of telomerase activity) was also comparable between prototype and variant E6 in this study. Instead, differences in the expression levels of several enzymes involved in metabolic activities were detected in E6/E7 and AA/E7 PHFKs.
Changes in cellular carbohydrate metabolism are a hallmark of malignant transformation and represent one of the earliest discernible events in tumorigenesis (Zwerschke et al., 2000) . HPV oncoproteins have previously been shown to alter carbohydrate metabolism (Zwerschke et al., 2000; Mazurek et al., 2001) . HPV16 E7 is shown to target the glycolytic control enzyme, pyruvate kinase M2 (a key player in reprogramming cellular carbohydrate metabolism in tumors), such that pyruvate kinase M2 is shifted to the tumor specific, dimeric form that possesses decreased substrate affinity (Mazurek et al., 2001) . This study provides evidence that the E6 oncoprotein of HPV16 may have an additional role in modulating carbohydrate and other metabolic activities.
A striking observation from our studies was the decreased expression of IDH isoforms 1 and 2 in AA/E7 compared with E6/E7 PHFKs. IDH isoforms are ratelimiting enzymes, converting isocitrate into alphaketoglutarate in the mitochondria (IDH2, tri-carboxylic acid cycle) and in the cytosol (IDH1, amino acid metabolism). The tri-carboxylic acid cycle is subverted in many tumors and indeed all proliferating cells in favor of aerobic glycolysis, a phenomenon known as the Warburg effect (Vander Heiden et al., 2009 ). This effect is further reflected by the higher glyceraldehyde 3-phosphate dehydrogenase and pyruvate kinase M2 levels in AA/E7 compared with E6/E7 PHFKs and suggest enhanced aerobic glycolysis as an underlying mechanism for the higher immortalizing and transforming potential of AA/E7. Indeed, the Warburg effect has been reported to be essential for immortalization and transformation, as it renders cells resistant to oxidative stress and adaptive to hypoxia (Kondoh, 2008) . Interestingly, disruption of an extra-mitochondrial process, characterized by reduced IDH1 activity and caused by tumor-associated mutations, has recently been reported for glioblastoma multiforme, a malignant brain tumor (Zhao et al., 2009) . Reduced IDH1 activity leads to low levels of alpha-ketoglutarate in the cytosol and activation of hypoxia-induced factor, which promotes the transcription of genes functioning in energy metabolism, growth and differentiation (Pollard and Ratcliffe, 2009) . A similar effect may hold true for some HPV-infected cells, albeit with a different underlying mechanism. Further study is required to determine the effects and causes of reduced levels of IDH1 in the AA/E7 line.
Reduced expression of the AKR1C1 in AA/E7 compared with E6/E7 PHFKs was another interesting observation. Reduced levels of AKR1C1 have been observed in breast cancer cell lines and paired tumor and normal tissue samples (Ji et al., 2004) . The AKR1C isoforms control production of estrogens and androgens, therefore any deregulation in the levels or activity of these enzymes can alter the local hormone ratios in tissues and affect proliferation (Penning and Byrns, 2009) . Reduced levels of the AKR1C1 in AA/E7 PHFKs may alter the local steroid hormone environment in infected cells to promote proliferation, a novel observation that merits further study.
In summary, HPV16 AA/E7 PHFKs reflect a phenotype more reminiscent of transformed cells than HPV16 E6/E7 PHFKs. Our studies suggest that AA/E7 may alter the regulation of the cellular energy generating system by differentially modulating metabolic enzymes and their associated pathways. These results introduce a new paradigm and warrant further studies on the mechanisms behind how primary human keratinocytes are immortalized and transformed into malignant tumors by viral oncoproteins of HPV16.
Materials and methods

Cell culture
PHFKs were obtained from Cell Applications, Inc. (San Diego, CA, USA) and sub-cultured using the recommended serum-free medium from the supplier. Cells were HPV16 E6 variants C Richard et al grown without feeders throughout the study, as suggested by the supplier. When harvesting, trypsin-EDTA (Invitrogen, Burlington, ON, Canada) was used and inactivated with trypsin neutralizing solution, as recommended by the supplier (Cell Applications). Cells were passaged when they reached 80% confluency and were counted with a Coulter counter after each passage. Throughout the study, 125 000 cells were re-plated after trypsinization.
Retroviral transduction
The HPV16 E7 gene, the E6 gene from prototype (E6) or the Q14H/H78Y/L83V AA variant were separately cloned into the pLXSN retroviral vector and used to transfect Phoenix helper cells by calcium phosphate precipitation (Clonetech, Heidelberg, Germany) as previously described (Zehbe et al., 2009) . After 48 h, the viral supernatant (in the presence of polybrene (1 mg/ml)) was used to infect (for 3 h) passage 3 PHFK cultures: empty vector, E6 and E7 (E6/E7), or AA and E7 (AA/E7). Transductions were performed in triplicate. To avoid supernatant serum-induced differentiation, serum-free keratinocyte medium (Cell Applications) was then added 1:1 and maintained for a further 12 h. For stable transduction, PHFKs were kept in keratinocyte medium for 48 h and were thereafter selected with 100 mg/ml G418. Resistant clones in the Petri dishes were pooled and further grown as mass cultures.
Quantitative real-time PCR Total RNA from the various cell clones was extracted using the RNAqueous kit from Ambion (Applied Biosystems (ABI), Foster City, CA, USA), integrity-tested/quantified using the Experion Automated Electrophoresis system (Bio-Rad, Mississauga, ON, CA), and reverse-transcribed using the high-capacity complementary DNA Archive kit (ABI), as described (DeCarlo et al., 2008) . For HPV16 E6, E7 (assay on demand), hTERT, and the housekeeping gene HPRT1, TaqMan primers were obtained from ABI. Quantitative reverse transcriptase-PCR using TaqMan chemistry was performed in triplicate using a 7500 ABI cycler, as described (DeCarlo et al., 2008) .
Western blot
To determine the levels of p53, p16 or actin in each of the keratinocyte lines, cells were trypsinized and subsequently lysed in ice-cold lysis buffer (10 mM Tris, pH 8.0, 0.25 M sucrose, 0.2 M NaCl, 2 mM MgCl 2 , 1 mM CaCl 2 , 1% Triton X-100 and 1 mM phenylmethylsulphonyl fluoride) for 20 min and centrifuged at 14 000 revolutions per minute for 20 min at 4 1C in a microcentrifuge. Between 30-50 ug of protein lysate was loaded in each lane of a 12% sodium dodecyl sulfate-polyacrylamide gel, electrophoresed, transferred onto a polyvinylidene difluoride membrane (Millipore, Kingston, ON, Canada), and immunoblotted with either mouse anti-p53 (clone DO-7, DAKO, Mississauga, ON, Canada), mouse anti-p16 (MTM Laboratories, Heidelberg, Germany) or goat anti-actin (sc-1616, Santa Cruz Biotechnologies, Heidelberg, Germany) at a dilution of 1:1000. Detection was achieved using the ECL Plus Western Detection Kit (Amersham, Piscataway, NJ, USA).
Flow cytometry
Cell cycle analysis was performed after incubating the AA/E7, E6/E7 or vector alone PHFKs in 0.5 nM AD for 24 h. The cells were fixed in cold 75% ethanol overnight. The fixed cells were washed with phosphate-buffered saline, then incubated in phosphate-buffered saline containing RNase (50 mg/ml) and propidium iodide (5 mg/ml) and the suspension was analyzed by flow cytometry on a FACSCalibur flow cytometer (Becton Dickinson, Mississauga, ON, Canada). Apoptosis was induced by maintaining the PHFKs in semi-solid medium for 24 h, as described previously (Zehbe et al., 2009) . Cells were washed three times with phosphate-buffered saline, then analyzed by flow cytometry using the annexin V-FITC assay (Sigma, Oakville, ON, Canada).
Organotypic raft cultures and immunofluorescence Raft cultures derived from E6/E7 and AA/E7 PHFKs were grown in triplicate, as described (Zehbe et al., 2009) . Immunofluorescence on raft culture sections was performed using the appropriate primary antibodies-a rabbit anti-K5 polyclonal antibody (#24647, Abcam, Cambridge, MA, USA), a mouse anti-K10 monoclonal antibody or a mouse anti-Ki67 (both from DAKO)-followed by secondary antibodiesAlexaFluor 488 donkey anti-rabbit or AlexaFluor 594 donkey anti-mouse-as described (Zehbe et al., 2009) . Ki67 was detected using a peroxidase-based reporter molecule system as described (Zehbe et al., 1999) .
Transformation in vitro assay
Keratinocyte cultures from passage 65, as well as negative and positive control cells (parental PHFKs from passage 3 and HeLa cells, respectively), were assessed for their ability to form colonies in semi-soft agar using the CytoSelect 96-well Cell Transformation Kit (Cell Biolabs, Inc., Burlington, ON, Canada). Five thousand cells per well were seeded in triplicate in a 96-well plate. After 10 days, colony formation was documented microscopically, then the agar was solubilized and the cells lysed, as recommended by the supplier. MTT assay was then performed to quantify cell viability (yellow tetrazole is reduced to purple formazan in the mitochondria of living cells). This product was dissolved in sodium dodecyl sulfate (provided in the transformation kit) to produce a colored solution, which was then measured at 570 nm by a microtiter spectrophotometer (BioTek, Nepean, ON, Canada). Two-dimensional gel electrophoresis, matrix-assisted laser desorption/ionization and mass spectrometry Protein samples (60 mg) were focused on 11 cm, immobilized, linear pH gradient (pH 3-10) strip gels (Bio-Rad Laboratories) for a total of 35 000 VHr at 8000 V. Second dimension electrophoresis was carried out using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Gels were stained overnight in SYPRO Ruby protein gel stain (Bio-Rad Laboratories) and scanned on a FX Molecular Imager instrument at 50 mm resolution (Bio-Rad Laboratories). Scanned images of gels were analyzed using PD Quest Advanced v. 8.0 software (Bio-Rad Laboratories).
In-gel trypsin digestion and generation of peptide spectra by matrix-assisted laser desorption/ionization were performed as described previously, with some modifications (Naryzhny and Lee, 2007) . The produced peptides were collected directly from the gel plug digest, mixed (1:1) with a-cyano-4-hydroxycinnamic acid matrix solution (Fluka, Buchs, Switzerland), 10 mg/ml, in 50% acetonitrile, 20% ethanol, 0.01% trifluoroacetic acid, applied to the target plate, crystallized and analyzed by matrix-assisted laser desorption/ionization on a Micro MX instrument (Waters Inc., Milford, MA, USA). Spectra were acquired in positive reflection mode (1100-3000 Da mass range) using a total of 150 shots in a random pattern across the spotted sample, and were processed using MassLynx Global version 4.0 software (Waters Inc.). Peak lists were obtained from raw data after smoothing, background subtraction and data centroiding. Internal calibration was carried out using trypsin-autolysis fragments at 1045.5642 and 2211.1046 Da. Peptide mass fingerprinting analysis was carried out using Aldente (http://ca.expasy.org/tools), or MasScot (http://www.matrixscience.com) software programs. The protein databases searched using Aldente were UniProtKB/SwissProt release 56.9 of 03 March 2009 and UniProtKB/TrEMBL release 39.9 of 03 March 2009. The databases searched using MASCOT were MSDB 20060831, SwissProt 57.2 and NCBInr 20090606. Searches were limited to the taxon Homo sapiens and single positive charge ions, with modifications to cysteine residues and single missed cleavages accounted for. Significant matches recovered using the Aldente software showed scores 415.0. Confirmation of protein identities was performed using the MasScot software. Spots with intensities below 200 parts per million were considered below the limits of detection. In the PD Quest spot analysis, one of the AA/E7 gels was selected as the 'master' to which the other gels were compared. Spots were added to the master gel from the other gels if they were present in at least one of the three gels in each set.
Statistical analysis
Cell culture data were analyzed by the Wilcoxon signed-rank test or the Fisher's exact test. Data from biochemical assays and two-dimensional gel electrophoresis were calculated using the two-tailed Student's t-test. Differences were considered significant at Po0.05.
